ARS Pharmaceuticals adds Dr. Rajeev Dadoo and Dr. Peter Kolchinsky to Board along with raising $55m Series D funding led by SR One

– USA, CA –  ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions potentially leading to anaphylaxis, has closed on a Series D financing of $55 million led by SR One with participation from RA Capital Management, and one other U.S.-based,…

DiCE Molecules welcomes Dr. Jake Simson to its Board along with raising $80m Series C financing led by RA Capital Management

– USA, CA –  DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform to discover and develop next-generation therapeutics in immunology, today announced the completion of an $80 million Series C financing led by RA Capital Management alongside new investors including Eventide Asset Management, New Leaf Venture Partners, Soleus Capital, Driehaus Capital Management, Osage University Partners and Asymmetry Capital Management.…